SFTA1P and liver cancer: The lncRNA SFTA1P acts as an oncogene and promotes the growth and invasion of lung (Du et al., 2020; Zhu et al., 2021) and liver cancers (Huang et al., 2020) in various signaling pathways, such as mTOR signaling pathway, AKT signaling pathway.